Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dieter Riesenberg is active.

Publication


Featured researches published by Dieter Riesenberg.


Applied Microbiology and Biotechnology | 1996

High volumetric yields of functional dimeric miniantibodies in Escherichia coli, using an optimized expression vector and high-cell-density fermentation under non-limited growth conditions

Uwe Horn; Wolfgang Strittmatter; Anke Krebber; Uwe Knüpfer; Marian Kujau; Rolf Wenderoth; Kristian M. Müller; Siegfried Matzku; Andreas Plückthun; Dieter Riesenberg

Abstract Functional bivalent miniantibodies, directed against the epidermal growth factor receptor, accumulated to more than 3 gl−1 in high-cell-density cultures of Escherichia coli RV308(pHKK) on a pilot scale. The miniantibodies consist of scFv fragments with a C-termi-nal hinge followed by a helix-turn-helix motif, which homodimerizes in vivo. The improved expression vector pHKK is characterized by the hok/sok suicide system, improving plasmid maintenance, and the inducible lac p/o promoter system with the very strong T7g10 Shine-Dalgarno sequence. The expression unit is flanked by terminators. The prototrophic RV308 cells were cultivated in glucose mineral salt medium and reached a cell density of 145 g dry biomass l−1 after 33 h. After induction, growth continued almost unchanged for a further 4 h with concomitant miniantibody formation. In the fed-batch phase, the concentration of glucose was kept almost constant at the physiological level of approximately 1.5 g l−1, using on-line flow injection analysis for control. Surprisingly, E. coli RV308(pHKK) did not accumulate significant amounts of the metabolic by-product acetate under these unlimited aerobic growth conditions.


Applied Microbiology and Biotechnology | 1992

Improvement of recombinant gene expression in Escherichia coli for glucose-controlled continuous and fed-batch cultures

Volker Schroeckh; Manfred Hartmann; Eckard Birch-Hirschfeld; Dieter Riesenberg

SummaryEscherichia coli TG1 (pHRW500) permanently expressed the human interferon α1 gene (ifnα1) directed by the tryptophan promoter (trpP.O) during continuous and fed-batch cultivation with a limited supply of glucose. The expression of ifnα1 could be improved after insertion of the catabolite activator region (cap) upstream to trpP.O during cultivation of the modified E. coli TG1(pHRW500cap) in glucose-controlled continuous and fed-batch cultures. The cap-mediated stimulatory effect on the expression of cap-trpP.O-ifnα1 increased with decreasing dilution rate. These results are in line with the increase in the level of cAMP with declining dilution rate and the well-known positive effects of cAMP-catabolite gene activator protein (CAP) at the transcriptional level. In addition, expression of the galactokinase gene (trpP.O-galK) in E. coli TG1(pDR720) could be improved in the same way with cap-trpP.O-galK in E. coli TG1(pDR720cap). Determinations of plasmid copy numbers, cellular amounts of galactokinase-mRNA, activity of galactokinase (AGalK) and the concentration of galactokinase at various dilution rates (D) strengthen the conclusion that the increase in AGalK with decreasing D was indeed due to the cap-mediated enhancement of transcription of the galK gene. We suggest that expression of other recombinant genes directed by various promoters that allow permanent transcription during growth with limited glucose supply in chemostat and fed-batch fermentors can be improved by appropriate insertion of the cap region.


Journal of Biotechnology | 1996

Formation of recombinant proteins in Escherichia coli under control of a nitrogen regulated promoter at low and high cell densities

Volker Schroeckh; Marian Kujau; Uwe Knüpfer; Rolf Wenderoth; J. Mörbe; Dieter Riesenberg

The use of a modified Escherichia coli glnAP2 promoter results in the formation of both homologous and heterologous, cytoplasmic and periplasmic recombinant proteins in a nitrogen concentration dependent manner. As in the E. coli nitrogen regulatory system, glnAP2 controlled gene expression is induced when ammonium concentration in the growth medium is below 1 mM (nitrogen limitation), otherwise only extremely low expression of recombinant genes is observed. Both high cell density cultivations (HCDC) and low cell density cultivations (LCDC) gave similar results for inducibility and formation of the following recombinant proteins: chloramphenicol-acetyltransferase, phosphorylcholine binding mini-antibodies (scFv-dhlx of McPC603) and K1-streptokinase. Recombinant proteins were formed in quantities of about 2-3% of total cellular protein. At low cell densities, slightly higher quantities resulted under partial nitrogen limitations than under total nitrogen limitation. In contrast, high cell density cultivations resulted in lower product concentrations at partial nitrogen limitation compared with total nitrogen limitation. These lowered product concentrations were probably due to the very high amounts of K+ or Na+ ions which accumulated during pH-regulation, thereby disturbing growth. HCDC under partial nitrogen limitation decreased proteolysis of recombinant proteins, therefore reduced amounts of proteases are considered to be responsible.


Journal of Biotechnology | 1999

The use of elements of the E. coli Ntr-system for the design of an optimized recombinant expression system for high cell density cultivations

Volker Schroeckh; Rolf Wenderoth; Marian Kujau; Uwe Knüpfer; Dieter Riesenberg

The inducible glnA promoter 2 of the E. coli glutamine synthetase gene is suitable as an expression unit for the production of recombinant proteins at low and high cell densities. It is active when the concentration of ammonium as the sole nitrogen source in the culture medium is below 1 mM. This nitrogen regulatory system was optimized by introduction of expression cassettes consisting of additional elements of the ntr-system. These artificial constructions result in enhanced recombinant gene expression in the production phase. Furthermore, the basic recombinant protein level during the growth phase is reduced due to a tighter promoter control. A three- to four-fold higher accumulation of chloramphenicol-acetyltransferase (as reporter protein) and of anti-EGF-receptor miniantibodies was achieved by increasing the amount of the final regulator molecule NtrC approximately P via plasmidal co-expression of the ntrC gene. The introduction of a modified glnA promoter 1 inverse to glnAp2 lowered the basic activity of glnAp2 to about one half. It is assumed that under nitrogen excess conditions sigma 70-RNA polymerase binds at glnAp1 and thereby prevents most of the binding of sigma 54-RNA polymerase at glnAp2. The optimized expression systems were successfully applied in low and high cell density cultivations. In the fed-batch phase of high cell density cultivations recombinant protein formation was induced through external nitrogen limitation under FIA-controlled concentration of glucose as carbon source.


Microbiological Research | 1999

Co-operative effects of protein engineering and vector optimization on high yield expression of functional bivalent miniantibodies in Escherichia coli

Marian Kujau; Dieter Riesenberg

The volumetric yield of functional phosphocholine-binding miniantibodies could be increased in E. coli fermentations by the combination of the following approaches: Firstly, miniantibody mutants with amino acid exchanges in the VH chain leading to improved folding were expressed. Secondly, the expression vector was stabilized by an efficient suicide system to prevent plasmid loss. Thirdly, the cells were grown to high cell densities in a stirred tank reactor.


Microbiological Research | 2000

Expression of soluble, recombinant αvβ3 integrin fragments in Escherichia coli

V. Schroeckh; P. Hortschansky; S. Fricke; G.A. Luckenbach; Dieter Riesenberg

Abstract No prokaryotic expression of integrin αvβ3 has been reported so far. We report here the expression of C-terminally truncated αvβ3 receptors in μ considering the known features required for dimerization and ligand binding. The expressed protein was insoluble despite of the addition of ‘solubilizers’ to the culture medium. Osmotic stress conditions combined with added exogenous solutes resulted in a small part of soluble receptor. The αvβ3 variants were purified from inclusion bodies or from soluble cytoplasmic maltose binding protein fusions. Heterodimerization of the subunits was proved by immunoprecipitation assays. Receptor-ligand binding was found to depend on the concentration. A competition assay with RGD peptides referred to unspecific receptorligand interaction. The latter fact was consistent with the finding that soluble receptors did not bind on RGD peptidecoupled sepharose (GRGDSPK sepharose).


Nature Biotechnology | 1993

Improved bivalent miniantibodies, with identical avidity as whole antibodies, produced by high cell density fermentation of Escherichia coli.

Peter Pack; Marian Kujau; Volker Schroeckh; Uwe Knüpfer; Rolf Wenderoth; Dieter Riesenberg; Andreas Plückthun


Archive | 1996

Process for the preparation of recombinant proteins in e.coli by high cell density fermentation

Wolfgang Strittmatter; Siegfried Matzku; Dieter Riesenberg; Uwe Horn; Uwe Knüpeer; Marian Kujau; Rolf Wenderoth; Andreas Plückthun; Anke Krebber


Archive | 2000

Molecular probes for targeting of cell density-indicating compounds

Dieter Riesenberg; Volker Schroeckh; Burkhard Gitter; Wolfgang Neuberger


Archive | 1999

Verfahren zur Herstellung von dimeren, biologisch aktiven knochenmorphogenetischen Proteinen

Peter Hortschansky; Volker Schroeckh; Beatrix Fahnert; Dieter Riesenberg

Collaboration


Dive into the Dieter Riesenberg's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge